throbber
15-2067 Docket
`
`Page 1 of 10
`
`Docketed: 09/25/2015
`
`General Docket
`United States Court of Appeals for the Federal Circuit
`
`Court of Appeals Docket #: 15-2067
`Nature of Suit: 830 Patent Infringement (Fed. Question)
`Eli Lilly and Company v. Teva Parenteral Medicines
`Appeal From: United States District Court for the Southern District of Indiana
`Fee Status: fee paid
`Case Type Information:
` 1) Civil Private
` 2) -
` 3) -
`Originating Court Information:
`District: 0756-1 : 1:10-cv-01376-TWP-DKL
`Trial Judge: Tonya Walton Pratt, United States District Judge
` Date Filed: 10/29/2010
` Date NOA Filed:
` 09/21/2015
`Prior Cases:
`14-1455 Date Filed: 05/05/2014 Date Disposed: 07/25/2014 Disposition: Remanded
`
` Date Rec'd COA:
` 09/22/2015
`
`Current Cases:
` None
`
`ELI LILLY AND COMPANY
` Plaintiff - Appellee
`
`Adam Lawrence Perlman, -
`Direct: 202-434-5149
`Email: aperlman@wc.com
`Fax: 202-434-5029
`[LD NTC Retained]
`Williams & Connolly LLP
`Firm: 202-434-5000
`725 12th Street, NW
`Washington, DC 20005-5901
`
`Bruce Genderson
`Direct: 202-434-5999
`Email: bgenderson@wc.com
`[COR NTC Retained]
`Williams & Connolly LLP
`Firm: 202-434-5000
`725 12th Street, NW
`Washington, DC 20005-5901
`
`Dov Philip Grossman
`Direct: 202-434-5000
`Email: dgrossman@wc.com
`[COR NTC Retained]
`Williams & Connolly LLP
`Firm: 202-434-5000
`725 12th Street, NW
`Washington, DC 20005-5901
`
`Allison B. Jones, Attorney
`Direct: 202-434-5478
`Email: ajones@wc.com
`Fax: 202-480-8428
`[COR NTC Retained]
`Williams & Connolly LLP
`Firm: 202-434-5000
`725 12th Street, NW
`Washington, DC 20005-5901
`
`David M. Krinsky, -
`Direct: 202-434-5338
`Email: dkrinsky@wc.com
`Fax: 202-480-8302
`[COR NTC Retained]
`Williams & Connolly LLP
`
`https://ecf.cafc.uscourts.gov/cmecf/servlet/TransportRoom
`
`3/16/2016
`
`Lilly Ex. 2013
`Sandoz v. Lilly IPR2016-00318
`
`

`
`15-2067 Docket
`
`Page 2 of 10
`
`v.
`
`TEVA PARENTERAL MEDICINES, INC.
` Defendant - Appellant
`
`Firm: 202-434-5000
`725 12th Street, NW
`Washington, DC 20005-5901
`
`Ellen E. Oberwetter, Trial Attorney
`Email: eoberwetter@wc.com
`[COR NTC Retained]
`Williams & Connolly LLP
`Firm: 202-434-5000
`725 12th Street, NW
`Washington, DC 20005-5901
`
`Daryl L. Wiesen, Attorney
`Direct: 617-570-1000
`Email: dwiesen@goodwinprocter.com
`Fax: 617-523-1231
`[LD NTC Retained]
`Goodwin Procter LLP
`53 State Street
`Exchange Place
`Boston, MA 02109
`
`Elaine Blais, Attorney
`Direct: 617-570-1000
`Email: eblais@goodwinprocter.com
`Fax: 617-523-1231
`[COR NTC Retained]
`Goodwin Procter LLP
`53 State Street
`Exchange Place
`Boston, MA 02109
`
`Michael B. Cottler
`Direct: 212-813-8800
`Email: mcottler@goodwinprocter.com
`Fax: 212-355-3333
`[COR NTC Retained]
`Goodwin Procter LLP
`The New York Times Building
`620 Eighth Avenue
`New York, NY 10018
`
`Natasha Elise Daughtrey
`Direct: 212-813-8800
`Email: ndaughtrey@goodwinprocter.com
`Fax: 212-355-3333
`[COR NTC Retained]
`Goodwin Procter LLP
`The New York Times Building
`620 Eighth Avenue
`New York, NY 10018
`
`Henry C. Dinger, Attorney
`Direct: 617-570-1000
`Email: hdinger@goodwinprocter.com
`Fax: 617-523-1231
`[COR NTC Retained]
`Goodwin Procter LLP
`53 State Street
`Exchange Place
`Boston, MA 02109
`
`Brian Joseph Prew
`Direct: 212-813-8800
`Email: BPrew@goodwinprocter.com
`[COR NTC Retained]
`Goodwin Procter LLP
`The New York Times Building
`620 Eighth Avenue
`New York, NY 10018
`
`https://ecf.cafc.uscourts.gov/cmecf/servlet/TransportRoom
`
`3/16/2016
`
`Lilly Ex. 2013
`Sandoz v. Lilly IPR2016-00318
`
`

`
`15-2067 Docket
`
`Page 3 of 10
`
`APP PHARMACEUTICALS LLC
` Defendant - Appellant
`
`PLIVA HRVATSKA D.O.O.
` Defendant - Appellant
`
`Emily L. Rapalino
`Direct: 617-570-1000
`Email: erapalino@goodwinprocter.com
`Fax: 617-523-1231
`[COR NTC Retained]
`Goodwin Procter LLP
`53 State Street
`Exchange Place
`Boston, MA 02109
`
`Daryl L. Wiesen, Attorney
`Direct: 617-570-1000
`[LD NTC Retained]
`(see above)
`
`Elaine Blais, Attorney
`Direct: 617-570-1000
`[COR NTC Retained]
`(see above)
`
`Michael B. Cottler
`Direct: 212-813-8800
`[COR NTC Retained]
`(see above)
`
`Natasha Elise Daughtrey
`Direct: 212-813-8800
`[COR NTC Retained]
`(see above)
`
`Henry C. Dinger, Attorney
`Direct: 617-570-1000
`[COR NTC Retained]
`(see above)
`
`Brian Joseph Prew
`Direct: 212-813-8800
`[COR NTC Retained]
`(see above)
`
`Emily L. Rapalino
`Direct: 617-570-1000
`[COR NTC Retained]
`(see above)
`
`Daryl L. Wiesen, Attorney
`Direct: 617-570-1000
`[LD NTC Retained]
`(see above)
`
`Elaine Blais, Attorney
`Direct: 617-570-1000
`[COR NTC Retained]
`(see above)
`
`Michael B. Cottler
`Direct: 212-813-8800
`[COR NTC Retained]
`(see above)
`
`Natasha Elise Daughtrey
`Direct: 212-813-8800
`[COR NTC Retained]
`(see above)
`
`Henry C. Dinger, Attorney
`Direct: 617-570-1000
`[COR NTC Retained]
`(see above)
`
`Brian Joseph Prew
`
`https://ecf.cafc.uscourts.gov/cmecf/servlet/TransportRoom
`
`3/16/2016
`
`Lilly Ex. 2013
`Sandoz v. Lilly IPR2016-00318
`
`

`
`15-2067 Docket
`
`Page 4 of 10
`
`TEVA PHARMACEUTICALS USA, INC.
` Defendant - Appellant
`
`BARR LABORATORIES, INC.
` Defendant - Appellant
`
`Direct: 212-813-8800
`[COR NTC Retained]
`(see above)
`
`Emily L. Rapalino
`Direct: 617-570-1000
`[COR NTC Retained]
`(see above)
`
`Daryl L. Wiesen, Attorney
`Direct: 617-570-1000
`[LD NTC Retained]
`(see above)
`
`Elaine Blais, Attorney
`Direct: 617-570-1000
`[COR NTC Retained]
`(see above)
`
`Michael B. Cottler
`Direct: 212-813-8800
`[COR NTC Retained]
`(see above)
`
`Natasha Elise Daughtrey
`Direct: 212-813-8800
`[COR NTC Retained]
`(see above)
`
`Henry C. Dinger, Attorney
`Direct: 617-570-1000
`[COR NTC Retained]
`(see above)
`
`Brian Joseph Prew
`Direct: 212-813-8800
`[COR NTC Retained]
`(see above)
`
`Emily L. Rapalino
`Direct: 617-570-1000
`[COR NTC Retained]
`(see above)
`
`Daryl L. Wiesen, Attorney
`Direct: 617-570-1000
`[LD NTC Retained]
`(see above)
`
`Elaine Blais, Attorney
`Direct: 617-570-1000
`[COR NTC Retained]
`(see above)
`
`Michael B. Cottler
`Direct: 212-813-8800
`[COR NTC Retained]
`(see above)
`
`Natasha Elise Daughtrey
`Direct: 212-813-8800
`[COR NTC Retained]
`(see above)
`
`Henry C. Dinger, Attorney
`Direct: 617-570-1000
`[COR NTC Retained]
`(see above)
`
`Brian Joseph Prew
`Direct: 212-813-8800
`[COR NTC Retained]
`
`https://ecf.cafc.uscourts.gov/cmecf/servlet/TransportRoom
`
`3/16/2016
`
`Lilly Ex. 2013
`Sandoz v. Lilly IPR2016-00318
`
`

`
`15-2067 Docket
`
`Page 5 of 10
`
`------------------------------
`
`GENERIC PHARMACEUTICAL ASSOCIATION
` Amicus Curiae
`
`(see above)
`
`Emily L. Rapalino
`Direct: 617-570-1000
`[COR NTC Retained]
`(see above)
`
`Christina Jordan McCullough, Esq.
`Direct: 206-359-6897
`Email: cmccullough@perkinscoie.com
`Fax: 206-359-7897
`[LD NTC Retained]
`Perkins Coie, LLP
`Suite 4900
`1201 Third Avenue
`Seattle, WA 98101
`
`Shannon Bloodworth, Attorney
`Direct: 202-654-6200
`Email: sbloodworth@perkinscoie.com
`Fax: 202-654-6211
`[COR NTC Retained]
`Perkins Coie, LLP
`Firm: 202-654-6200
`700 Thirteenth Street, NW
`Washington, DC 20005
`
`https://ecf.cafc.uscourts.gov/cmecf/servlet/TransportRoom
`
`3/16/2016
`
`Lilly Ex. 2013
`Sandoz v. Lilly IPR2016-00318
`
`

`
`15-2067 Docket
`
`Page 6 of 10
`
`ELI LILLY AND COMPANY,
`
` Plaintiff - Appellee
`
`v.
`
`TEVA PARENTERAL MEDICINES, INC., APP PHARMACEUTICALS LLC, PLIVA HRVATSKA D.O.O., TEVA PHARMACEUTICALS
`USA, INC., BARR LABORATORIES, INC.,
`
` Defendants - Appellants
`
`https://ecf.cafc.uscourts.gov/cmecf/servlet/TransportRoom
`
`3/16/2016
`
`Lilly Ex. 2013
`Sandoz v. Lilly IPR2016-00318
`
`

`
`15-2067 Docket
`
`Page 7 of 10
`
`09/25/2015
`
` 1
`140 pg, 1.77 MB
`
`10/09/2015
`
`10/09/2015
`
`10/09/2015
`
`10/09/2015
`
`10/09/2015
`
`10/09/2015
`
`10/09/2015
`
`10/09/2015
`
`10/09/2015
`
`10/09/2015
`
`10/09/2015
`
`10/09/2015
`
`10/09/2015
`
`10/09/2015
`
`10/09/2015
`
` 2
`2 pg, 147.69 KB
`
` 3
`2 pg, 148.39 KB
`
` 4
`2 pg, 155.42 KB
`
` 5
`2 pg, 148.12 KB
`
` 6
`2 pg, 151.23 KB
`
` 7
`2 pg, 156.9 KB
`
` 8
`3 pg, 179.99 KB
`
` 9
`3 pg, 74.52 KB
`
` 10
`2 pg, 1.03 MB
`
` 11
`2 pg, 1.08 MB
`
` 12
`2 pg, 1.08 MB
`
` 13
`2 pg, 1.04 MB
`
` 14
`2 pg, 1.08 MB
`
` 15
`2 pg, 1.09 MB
`
` 16
`2 pg, 1.09 MB
`
`10/09/2015
`
` 17
`4 pg, 535.34 KB
`
`10/09/2015
`
` 18
`2 pg, 675.9 KB
`
`10/09/2015
`
` 19
`2 pg, 87.04 KB
`
`11/02/2015
`
` 20
`12 pg, 151.79 KB
`
`11/05/2015
`
` 21
`2 pg, 62.23 KB
`
`Appeal docketed. Received: 09/22/2015. [275100]
`Entry of Appearance due 10/09/2015. Certificate of Interest is due on 10/09/2015. Docketing Statement due
`10/09/2015. Appellant/Petitioner's brief is due 11/24/2015.
`Entry of appearance for Adam L. Perlman as principal counsel for Appellee Eli Lilly and Company. Service:
`10/09/2015 by email. [279427]
`Entry of appearance for Bruce R. Genderson as of counsel for Appellee Eli Lilly and Company. Service:
`10/09/2015 by email. [279430]
`Entry of appearance for Ellen E. Oberwetter as of counsel for Appellee Eli Lilly and Company. Service:
`10/09/2015 by email. [279431]
`Entry of appearance for Dov P. Grossman as of counsel for Appellee Eli Lilly and Company. Service:
`10/09/2015 by email. [279432]
`Entry of appearance for David M. Krinsky as of counsel for Appellee Eli Lilly and Company. Service:
`10/09/2015 by email. [279433]
`Entry of appearance for Allison B. Jones as of counsel for Appellee Eli Lilly and Company. Service:
`10/09/2015 by email. [279435]
`Certificate of Interest for the Appellee Eli Lilly and Company. Service: 10/09/2015 by email. [279436]
`
`Docketing Statement for the Appellee Eli Lilly and Company. Service: 10/09/2015 by email. [279437]
`
`Entry of appearance for Daryl L. Wiesen as principal counsel for Appellants APP Pharmaceuticals LLC,
`Barr Laboratories, Inc., Pliva Hrvatska D.O.O., Teva Parenteral Medicines, Inc. and Teva Pharmaceuticals
`USA, Inc.. Service: 10/09/2015 by email. [279462]
`Entry of appearance for Elaine Harrmann Blais as of counsel for Appellants APP Pharmaceuticals LLC,
`Barr Laboratories, Inc., Pliva Hrvatska D.O.O., Teva Parenteral Medicines, Inc. and Teva Pharmaceuticals
`USA, Inc.. Service: 10/09/2015 by email. [279469]
`Entry of appearance for Emily L. Rapalino as of counsel for Appellants APP Pharmaceuticals LLC, Barr
`Laboratories, Inc., Pliva Hrvatska D.O.O., Teva Parenteral Medicines, Inc. and Teva Pharmaceuticals USA,
`Inc.. Service: 10/09/2015 by email. [279479]
`Entry of appearance for Michael B. Cottler as of counsel for Appellants APP Pharmaceuticals LLC, Barr
`Laboratories, Inc., Pliva Hrvatska D.O.O., Teva Parenteral Medicines, Inc. and Teva Pharmaceuticals USA,
`Inc.. Service: 10/09/2015 by email. [279483]
`Entry of appearance for Elaine Herrmann Blais as of counsel for Appellants APP Pharmaceuticals LLC,
`Barr Laboratories, Inc., Pliva Hrvatska D.O.O., Teva Parenteral Medicines, Inc. and Teva Pharmaceuticals
`USA, Inc.. Service: 10/09/2015 by email. [279484]
`Entry of appearance for Brian J. Prew as of counsel for Appellants APP Pharmaceuticals LLC, Barr
`Laboratories, Inc., Pliva Hrvatska D.O.O., Teva Parenteral Medicines, Inc. and Teva Pharmaceuticals USA,
`Inc.. Service: 10/09/2015 by email. [279487]
`Entry of appearance for Natasha E. Daughtrey as of counsel for Appellants APP Pharmaceuticals LLC,
`Barr Laboratories, Inc., Pliva Hrvatska D.O.O., Teva Parenteral Medicines, Inc. and Teva Pharmaceuticals
`USA, Inc.. Service: 10/09/2015 by email. [279491]
`Docketing Statement for the Appellants APP Pharmaceuticals LLC, Barr Laboratories, Inc., Pliva Hrvatska
`D.O.O., Teva Parenteral Medicines, Inc. and Teva Pharmaceuticals USA, Inc.. Service: 10/09/2015 by
`email. [279493]
`Certificate of Interest for the Appellants APP Pharmaceuticals LLC, Barr Laboratories, Inc., Pliva Hrvatska
`D.O.O., Teva Parenteral Medicines, Inc. and Teva Pharmaceuticals USA, Inc.. Service: 10/09/2015 by
`email. [279494]
`Transcript Purchase Order Form for the Appellants APP Pharmaceuticals LLC, Barr Laboratories, Inc.,
`Pliva Hrvatska D.O.O., Teva Parenteral Medicines, Inc. and Teva Pharmaceuticals USA, Inc. indicating that
`a transcript is already on file. Service: 10/09/2015 by email. [279495]
`MOTION of Appellants APP Pharmaceuticals LLC, Barr Laboratories, Inc., Pliva Hrvatska D.O.O., Teva
`Parenteral Medicines, Inc., Teva Pharmaceuticals USA, Inc. and Appellee Eli Lilly and Company to set
`briefing schedule. Response/Opposition is due 11/16/2015 [Consent: unopposed]. Service: 11/02/2015 by
`email, fax. [285187]
`ORDER granting motion to set briefing schedule [20] filed by Appellants Barr Laboratories, Inc., Teva
`Pharmaceuticals USA, Inc., APP Pharmaceuticals LLC, Teva Parenteral Medicines, Inc., Pliva Hrvatska
`D.O.O. and Appellee Eli Lilly and Company. Appellants' opening brief is due no later than 12/23/2015.
`Appellee’s response brief is due no later than 03/04/2016. Appellants’ reply brief is due no later than
`03/18/2016. Service: 11/05/2015 by clerk. [286626]
`
`https://ecf.cafc.uscourts.gov/cmecf/servlet/TransportRoom
`
`3/16/2016
`
`Lilly Ex. 2013
`Sandoz v. Lilly IPR2016-00318
`
`

`
`15-2067 Docket
`
`Page 8 of 10
`
`12/09/2015
`
`12/09/2015
`
`12/09/2015
`
` 22
`2 pg, 129.42 KB
`
` 23
`2 pg, 199.96 KB
`
` 24
`3 pg, 69.73 KB
`
`12/10/2015
`
` 25
`
`12/22/2015
`
` 26
`2 pg, 541.69 KB
`
`12/23/2015
`
` 27
`160 pg, 2.05 MB
`
`12/23/2015
`
` 28
`160 pg, 2.1 MB
`
`12/30/2015
`
` 29
`
`01/06/2016
`
`01/06/2016
`
`01/15/2016
`
` 30
`6 pg, 23.34 KB
`
` 31
`27 pg, 79.71 KB
`
` 32
`2 pg, 64.6 KB
`
`01/15/2016
`
` 33
`27 pg, 81.05 KB
`
`01/19/2016
`
` 34
`
`03/04/2016
`
`03/04/2016
`
` 35
`74 pg, 277.06 KB
`
` 36
`74 pg, 274.35 KB
`
`03/09/2016
`
` 37
`7 pg, 18.83 KB
`
`03/10/2016
`
` 38
`
`03/10/2016
`
`03/11/2016
`
`03/11/2016
`
`03/11/2016
`
`03/11/2016
`
` 48
`
` 39
`7 pg, 190.28 KB
`
` 40
`3 pg, 211.29 KB
`
` 41
`3 pg, 190.03 KB
`
` 42
`0 pg, 0 KB
`
`Entry of appearance for Christina J. McCullough as principal counsel for Generic Pharmaceutical
`Association. Service: 12/09/2015 by email. [294962]
`Entry of appearance for Shannon M. Bloodworth as of counsel for Generic Pharmaceutical Association.
`Service: 12/09/2015 by email. [294963]
`MOTION of Generic Pharmaceutical Association to extend the time to 01/06/2016 to file the amicus curiae
`brief. Response/Opposition is due 12/28/2015 [Consent: unopposed]. Service: 12/09/2015 by email.
`[294966]
`**TEXT ONLY** ORDER granting motion to extend time to file amicus brief [24] amicus brief due
`01/06/2016. Service as of this date by Clerk of Court. This order has been issued without an attached
`document and is official and binding. [295022]
`Entry of appearance for Henry C. Dinger as of counsel for Appellants APP Pharmaceuticals LLC, Barr
`Laboratories, Inc., Pliva Hrvatska D.O.O., Teva Parenteral Medicines, Inc. and Teva Pharmaceuticals USA,
`Inc.. Service: 12/22/2015 by email. [298249]
`TENDERED from Appellants APP Pharmaceuticals LLC, Barr Laboratories, Inc., Pliva Hrvatska D.O.O.,
`Teva Parenteral Medicines, Inc. and Teva Pharmaceuticals USA, Inc.. Title: OPENING BRIEF. Service:
`12/23/2015 by email. [298679]
`BRIEF FILED for Appellants APP Pharmaceuticals LLC, Barr Laboratories, Inc., Pliva Hrvatska D.O.O.,
`Teva Parenteral Medicines, Inc. and Teva Pharmaceuticals USA, Inc. [27]. Number of Pages: 63. Service:
`12/23/2015 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The
`paper copies of the brief should be received by the court on or before 01/04/2016. [299243]
`6 paper copies of the Opening Brief [28] received from Appellants APP Pharmaceuticals LLC, Barr
`Laboratories, Inc., Pliva Hrvatska D.O.O., Teva Parenteral Medicines, Inc. and Teva Pharmaceuticals USA,
`Inc.. [299584]
`MOTION of Amicus Curiae Generic Pharmaceutical Association for leave to file an amicus curiae brief.
`Response/Opposition is due 01/23/2015 [Consent: partial consent]. Service: 01/07/2015 by email. [300756]
`TENDERED from Amicus Curiae Generic Pharmaceutical Association. Title: AMICUS CURIAE BRIEF.
`Service: 01/06/2016 by email. [300759]
`ORDER filed granting motion for leave to file an amicus curiae brief [30] filed by Amicus Curiae Generic
`Pharmaceutical Association. The Generic Pharmaceutical Associations amicus brief is accepted for filing.
`Service: by. [303376]
`AMICUS BRIEF FILED for Generic Pharmaceutical Association [31]. Number of Pages: 20. Service:
`01/06/2016 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The
`paper copies of the brief should be received by the court on or before 01/20/2016. [303461]
`6 paper copies of the Amicus Brief [33] received from Amicus Curiae Generic Pharmaceutical Association.
`[303759]
`TENDERED from Appellee Eli Lilly and Company. Title: RESPONSE BRIEF. Service: 03/04/2016 by email.
`[316119]
`BRIEF FILED for Appellee Eli Lilly and Company [35]. Number of Pages: 64. Service: 03/04/2016 by email.
`Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the
`brief should be received by the court on or before 03/14/2016. [316287]
`MOTION of Appellants APP Pharmaceuticals LLC, Barr Laboratories, Inc., Pliva Hrvatska D.O.O., Teva
`Parenteral Medicines, Inc. and Teva Pharmaceuticals USA, Inc. to extend the time to 03/25/2016 at 11:59
`pm to file the reply brief. Response/Opposition is due 03/24/2016 [Consent: unopposed]. Service:
`03/09/2016 by email. [317307]
`**TEXT ONLY** ORDER granting motion to extend time to file reply brief [37] filed by Appellants Barr
`Laboratories, Inc., Teva Pharmaceuticals USA, Inc., APP Pharmaceuticals LLC, Teva Parenteral
`Medicines, Inc., and Pliva Hrvatska D.O.O. Reply brief is due 03/25/2016. Service as of this date by Clerk
`of Court. This order has been issued without an attached document and is official and binding. [317530]
`6 paper copies of the Opening Response Brief [36] received from Appellee Eli Lilly and Company. [318346]
`
`MOTION of Biotechnology Innovation Organization for leave to file an amicus curiae brief.
`Response/Opposition is due 03/26/2015 [Consent: partial consent]. Service: 03/11/2015 by email. [318063]
`Entry of appearance for David S. Forman as principal counsel for Biotechnology Innovation Organization.
`Service: 03/11/2016 by email. [318065]
`Entry of appearance for Hans Sauer as of counsel for Biotechnology Innovation Organization. Service:
`03/11/2016 by email. [318066]
`TENDERED from Biotechnology Innovation Organization Title: AMICUS CURIAE BRIEF. Service:
`03/11/2016 by email. [318067]
`
`https://ecf.cafc.uscourts.gov/cmecf/servlet/TransportRoom
`
`3/16/2016
`
`Lilly Ex. 2013
`Sandoz v. Lilly IPR2016-00318
`
`

`
`15-2067 Docket
`
`Page 9 of 10
`
`03/11/2016
`
`03/11/2016
`
`03/11/2016
`
`03/11/2016
`
` 43
`2 pg, 47.87 KB
`
` 44
`2 pg, 47.77 KB
`
` 45
`2 pg, 47.74 KB
`
` 46
`8 pg, 29.94 KB
`
`03/11/2016
`
` 47
`0 pg, 0 KB
`
`Entry of appearance for Kevin S. Prussia as principal counsel for Pharmaceutical Research and
`Manufacturers of America. Service: 03/11/2016 by email. [318070]
`Entry of appearance for Jamie T. Wisz as of counsel for Pharmaceutical Research and Manufacturers of
`America. Service: 03/11/2016 by email. [318072]
`Entry of appearance for Sameer Ahmed as of counsel for Pharmaceutical Research and Manufacturers of
`America. Service: 03/11/2016 by email. [318073]
`MOTION of Pharmaceutical Research and Manufacturers of America for leave to file an amicus curiae
`brief. Response/Opposition is due 03/24/2016 [Consent: partial consent]. Service: 03/11/2016 by email.
`[318077]
`TENDERED from Pharmaceutical Research and Manufacturers of America Title: AMICUS CURIAE BRIEF.
`Service: 03/11/2016 by email. [318078]
`
`https://ecf.cafc.uscourts.gov/cmecf/servlet/TransportRoom
`
`3/16/2016
`
`Lilly Ex. 2013
`Sandoz v. Lilly IPR2016-00318
`
`

`
`15-2067 Docket
`
`Page 10 of 10
`
`Clear All
`
` Documents and Docket Summary
` Documents Only
`
` Include Page Numbers
`
` Selected Size: 0 KB
`Selected Pages: 0
`Totals reflect accessible documents only and do not include unauthorized restricted documents.
`
`View Selected
`
`PACER Service Center
`Transaction Receipt
`03/16/2016 14:38:00
`
`PACER
`wc0010:2660228:0
`Login:
`Description: Docket Report
`(filtered)
`Billable
`Pages:
`
`5
`
`Client Code: 44561.0018
`
`Search
`Criteria:
`
`Cost:
`
`15-2067
`
`0.50
`
`https://ecf.cafc.uscourts.gov/cmecf/servlet/TransportRoom
`
`3/16/2016
`
`Lilly Ex. 2013
`Sandoz v. Lilly IPR2016-00318
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket